The vision of the company GlaxoSmithKline is for them to be able to become the leader in their industry. Not only in the terms of size but on how will they use the size to achieve their mission
The population of GlaxoSmithKline is 2,010.
GlaxoSmithKline was created in 2000.
Glaxosmithkline is actually a company that specializes in global pharmaceuticals, biologics, vaccines, and consumer healthcare. Glaxosmithkline has its headquarters in London, England.
The symbol for GlaxoSmithKline PLC in the NYSE is: GSK.
GlaxoSmithKline Pharmaceuticals Ltd's population is 3,500.
GlaxoSmithKline Pharmaceuticals Ltd was created in 1924.
GlaxoSmithKline, 2000-, chief executive officer.
GlaxoSmithKline
As of July 2014, the market cap for GlaxoSmithKline PLC (GSK) is $121,563,516,721.28.
No, GlaxoSmithKline does not own Beckman Coulter. Beckman Coulter is a subsidiary of Danaher Corporation, which acquired it in 2011. GlaxoSmithKline is a pharmaceutical and healthcare company, while Beckman Coulter specializes in biomedical laboratory instruments and reagents.
The largest pharmaceutical company in Great Britain is GlaxoSmithKline plc. GlaxoSmithKline is the fourth largest pharmaceutical company in the world.
The ticker symbol is GSK